EXTINA® (ketoconazole) Foam, 2% is used on the skin (topical) to
treat a skin condition called seborrheic dermatitis in patients 12 years of age
and older.
Important Safety Information
The most common side effects of EXTINA® Foam observed in clinical
studies (incidence greater than 1%) included application site burning (10%) and
application site reaction (6%).
EXTINA® Foam may result in contact sensitization, including an allergic
reaction that occurs only following sun exposure.
Apply EXTINA® Foam exactly as prescribed. Talk to your doctor if
your skin does not improve after 4 weeks of treatment.
Avoid contact with the eyes and other mucous membranes. EXTINA® Foam
is not for ophthalmic, oral or intravaginal use.
Keep the EXTINA® Foam can away from and do not spray it near fire,
open flame, or direct heat. EXTINA® Foam is flammable.
Click here for complete
Prescribing Information for
EXTINA® Foam
STIEFEL, STIEFEL & Design, EXTINA, VERSAFOAM, the V Design, VERSAFOAM-HF, VERSAFOAM-HF
& Design, STIEFELCARE and STIEFEL CARE & Design are registered trademarks of Stiefel
Laboratories, Inc.
You are encouraged to report the side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch
or call 1-800-FDA-1088.